Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 19/20 | 0.60 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.60 |
| ▸ | PREP | P48147 | 3/20 | 0.60 |
| ▸ | DPP8 | Q6V1X1 | 7/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.48 |
| ▸ | FAP | Q12884 | 4/20 | 0.47 |
| ▸ | PITRM1 | Q5JRX3 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2369832 | 1.00 | DPP4 (0.60) | DPP4DPP7PREPDPP8DPP9 | |
| SCHEMBL2769140 | 0.89 | DPP4 (0.75) | DPP4DPP7PREPDPP8DPP9 | |
| SCHEMBL2769136 | 0.89 | DPP4 (0.75) | DPP4DPP7PREPDPP8DPP9 | |
| SCHEMBL17376044 | 0.89 | DPP4 (0.52) | DPP4DPP7PREPDPP8DPP9 | |
| SCHEMBL7312806 | 0.85 | DPP4 (0.73) | DPP4DPP7PREPDPP8DPP9 | |
| SCHEMBL7312802 | 0.85 | DPP4 (0.73) | DPP4DPP7PREPDPP8DPP9 | |
| SCHEMBL9840411 | 0.85 | DPP4 (0.73) | DPP4DPP7PREPDPP8DPP9 | |
| SCHEMBL2196155 | 0.84 | DPP4 (0.78) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL7021069 | 0.84 | DPP4 (0.78) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL7403443 | 0.84 | DPP4 (0.78) | DPP4DPP7DPP8DPP9FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9550806-B2 | Immunogenic compositions against human progastrin peptides | ONKOLOGIX LTD. (US) | 2017-01-24 | — | — | US | disclosed |
| US-20140227301-A1 | IMMUNOGENIC COMPOSITIONS AGAINST HUMAN PROGASTRIN PEPTIDES | ONKOLOGIX LTD (US) | 2014-08-14 | — | — | US | disclosed |
| US-8674064-B2 | Immunogenic compositions against human progastrin peptides | ONKOLOGIX LTD (US) | 2014-03-18 | — | — | US | disclosed |
| CN-101797382-B | Anti-human progastrin polypeptide immune composition | QI SHENGMEI | 2013-11-20 | — | — | CN | disclosed |
| US-20130064841-A1 | IMMUNOGENIC COMPOSITIONS AGAINST HUMAN PROGASTRIN PEPTIDES | ONKOLOGIX LTD | 2013-03-14 | — | — | US | disclosed |
| WO-2011109106-A2 | IMMUNOGENIC COMPOSITIONS AGAINST HUMAN PROGASTRIN PEPTIDES | ONKOLOGIX LTD (US) | 2011-09-09 | — | — | WO | disclosed |
| CN-101797382-A | Anti-human progastrin polypeptide immune composition | SHENGMEI QI | 2010-08-11 | — | — | CN | disclosed |
| EP-0232165-B1 | Diagnostic method for gonorrhea by assay of IgA1 fragments | IMMUNOGON ASSOCIATES (US) | 1994-04-27 | — | — | EP | disclosed |
| EP-0324130-A2 | 8-Glycine, 16-X, Des-19-Leucine-Calcitonin | RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) | 1989-07-19 | — | — | EP | disclosed |
| US-4795702-A | Diagnostic method for gonorrhea by assay of IgA1 fragments | IMMUNOGON ASSOCIATES (US) | 1989-01-03 | — | — | US | disclosed |
| US-4469632-A | REDUCTION OF SERUM CALCIUM CONCENTRATION | ARMOUR PHARMACEUTICAL COMPANY (US) | 1984-09-04 | — | — | US | disclosed |
| WO-1984003279-A1 | DES-ASPARAGINE-3 CALCITONIN | ARMOUR PHARMA (US) | 1984-08-30 | — | — | WO | disclosed |
| WO-1984003280-A1 | GLYCINE-8 CALCITONIN | ARMOUR PHARMA (US) | 1984-08-30 | — | — | WO | disclosed |
| US-4414149-A | POLYPEPTIDE | ARMOUR PHARMACEUTICAL COMPANY (US) | 1983-11-08 | — | — | US | disclosed |
| US-4401593-A | CYCLIC POLYPEPTIDES | ARMOUR PHARMACEUTICAL COMPANY (US) | 1983-08-30 | — | — | US | disclosed |
| US-4388235-A | SYNTHETIC CALCITONIN | ARMOUR PHARMACEUTICAL COMPANY (US) | 1983-06-14 | — | — | US | disclosed |